Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.
Financial Results:
Pfizer Ltd reported Revenues for Q3FY25 of ₹538.00 Crores down from ₹540.00 Crore year on year, a fall of 0.37%.
Total Expenses for Q3FY25 of ₹409.00 Crores up from ₹408.00 Crores year on year, a rise of 0.25%.
Consolidated Net Profit of ₹128.00 Crores down 1.54% from ₹130.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹27.89, down 1.83% from ₹28.41 in the same quarter of the previous year.